Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-010-0963-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC